|
Market Closed -
Swiss Exchange
16:36:05 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 10.20 CHF | -4.37% |
|
+7.35% | +57.81% |
| Current month | -3.17% | ||
| 1 month | -3.17% |
Main features
| IE00BM8R0N95 | Fees | 0.5% | Dividend Policy | Market Cap | |
|---|---|---|---|---|---|
| Currency | CHF | AuM (GBP) | 48.36M | Replication Method | Direct (Physical) |
| Number of securities | 49 | AuM evolution | - | Date of creation | 03/11/2021 |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | Developed markets |
| Theme and Sector | BioTech & Genomics |
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the Index).
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CHF 10.20 | -4.37% | 69 |
| 29/10/26 | CHF 10.66 | +0.83% | 4 |
| 28/10/26 | CHF 10.58 | +5.11% | 1 |
| 27/10/26 | CHF 10.06 | +2.81% | 0 |
| 26/10/26 | CHF 9.787 | +3.02% | 0 |
Similar ETF
- Stock Market
- ETF
- GNOM ETF
Select your edition
All financial news and data tailored to specific country editions





















